This study is consistent with our previous study, which provided evidence that GSPE could inhibit tau peptide aggregation [12] and prevent oligomerization of Aβ  peptides into high molecular weight species in models of AD-amyloid neuropathology [10, 11]. The gene discussed is MAPT; the disease is Alzheimer disease.